Hypochromic Anaemia in Chronic Renal Failure - Role of Aluminium

Journal of Association of Physicians of India

Volumn 47, Issue 7, 1999, Pages 690-693

  Varma, P P ^a,d   Kumar, R ^b,d   Prasher, P K ^c,d   Roy, N D ^e  

^a Cl Spl Medicine and Nephrology   (India)

^b R and R Hospital (Army)   (India)

^c CH (SC)   (India)

^d Department of Pathology Command Hospital Southern Command   (India)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; HEMODIALYSIS FLUID;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; FEMALE; HUMAN; IRON DEFICIENCY ANEMIA; MALE; METABOLISM;

ADULT; ALUMINUM; ANEMIA, IRON-DEFICIENCY; FEMALE; HEMODIALYSIS SOLUTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE;

EID: 0033156672     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Esbach JW, Adamson JW. Haematological consequences of renal failure. In : The kidney. Eds Brenner BM and Rector FC. WB Saunders, Philadelphia. 1991; 4 : 2019-35.
2. Stevens J, Kurtz A, Winearls. Anaemia in chronic renal failure. In Oxford textbook of clinical nephrology. Eds. Cameron S, Davison AM, Grunfeld JP and Ritz E. Oxford University Press, Oxford. 1992; 1344-60.
3. Lazarus JM, Brenner BM. Chronic Renal Failure. In Harrison's principles of internal medicine. Eds, Fauci AS, Braunwald E. Isselbacher KJ, Wilson JD, Martin JB, and Kasper DL, Hauser SL, Longo DL. McGraw-Hill, New York. 1998; 14: 1513-20.
4. Lee GR. Microcytosis and the anaemia associated with impaired haemoglobin synthesis. In wintrobes clinical haematology. Ed Lee GR, Bithell TC, Foerester J, Athens JW and Luken JN. Lee and Febger. Philadelphia. 1993; 9 : 791-807.
5. Eschbach JW, Cook JD, Scribner BH, Finch CA. Iron balance in haemodialysis patients. Ann Intern Med 1997; 87 : 710-3.
6. Cunningham J, Sharman VL, Goodwyn FJ, Marsh FP. Do patients receiving haemodialysis need folic acid supplements. BMJ 1981; 282 : 1582-4.
7. Agarwal S, Sharma S, Kalra OP, Singh S, Madan N. Ferrokinetic studies and bone marrow status in patients with CRF. (Abstract). JAPI 1995; 43 : 889.
8. Chaudhary S, Rajat Kumar, Varma PP, Bahl A, Dham SK. Anaemia in CRF with special reference to bone marrow examination. (Abstract). JAPI 1995; 43 : 888-9.
9. Krause JR, Brubaker D, Kaplan S. Comparison of stainable iron in aspirated and needle biopsy specimens of bone marrow. Am J Clin Path 1979; 72 (i) : 68-70.
10. Eschbach JW, Egrie J, Downing M, et al. Correction of anaemia of end stage renal disease with recombinant human erythropoeitin. N Eng J Med 1987; 73 : 316-23.
11. Panda SK, Palit SK. The efficacy of recombinant human erythropoientin on the anaemia of chronic renal failure. Abs Indian J Nephrol (New Series) 1994; 4 (3).
12. Chugh KS, Marwaha N, Sakhuja V, Jha V. Clinical efficacy and safety of low dose human erythropoeitin. Abs 2C 0101. Asian Pacific Congress of Nephrology 1992.
13. Akmal M, Telfer N, Ansari AN, Massry SG. RBC survival in chronic renal failure, role of secondary hyperparathyroidism. J Clin Inves 1985; 76 : 1695-8.
14. Ricanati ES, Ott SM, Klein KL. Evaluation of bone in dialysis patients exposed to aluminium in dialysate. Kidney Int 1982; 21 : 176-80.
15. DeBroe ME, Haese PCD, Elsevier MM, Clement J, et al. Aluminium and end stage renal failure. Proc of 10th international congress of Nephrology. Ed Davison AM. Transmedia Europe limited. Phildelphia. 1988; 1086-118.
16. Rizvi SNA, Arora S, Athar N, Chauhan S, Khan HA. Study of serum Al levels and its correlation with the distribution of aluminium in bone, in patients chronic renal failure. Abs Indian Journal of Nephrology (New Series) 1994; 4 (3).
17. Lin JL, Kin MT, Len ML, et al. Long term effect of aluminium on haemoglobin in CRF patients. Nephron 1996; 74 : 33-8.
18. Rosenlof K, Fyhroist F, Tenhunen R, et al. Response of anaemia to EPO. Lancet 1990; 247 : 335.